Adaptive Biotechnologies Corp
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Seattle, WA
ADPT chart
What traders are saying about $ADPT
Latest postsAdaptive Biotechnologies Corp news
- Can You Still Buy Tempus AI Stock Today?
trefis.com ·
- Adaptive Biotechnologies Corp. (ADPT) Rallies on Earnings Beat, Raised Outlook, and Cash-Flow Targets
Yahoo Finance ·
- Adaptive Biotechnologies sees 33% MRD revenue g...
Pluang ·
- Adaptive Biotechnologies: Getting Paid Every Step Of The Way To A Myeloma Cure (ADPT)
Seeking Alpha ·
- Adaptive Biotechnologies (NASDAQ:ADPT) Stock Crosses Above Fifty Day Moving Average Following Insider Selling
MarketBeat ·
- Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Stock
MarketBeat ·
- Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Stock
MarketBeat ·
- Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 22 October
Investing.com Nigeria ·
- Adaptive Biotechnologies president and COO Julie Rubinstein sells $897k shares
Investing.com ·
- COO exercises options at $12.14 and sells 35,643 Adaptive Biotechnologies (ADPT) shares under a trading plan.
Stock Titan ·
- What Happens To Tempus AI Stock If Its Cash Burn Continues?
trefis.com ·
- Adaptive Biotechnologies (ADPT) Stock Looks Fully Valued Following Its Huge Three Year Run
Simply Wall Street ·
Adaptive Biotechnologies Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $277.0M | $179.0M | $170.3M | $185.3M |
| Net income | -$59.5M | -$159.5M | -$225.3M | -$200.2M |
| Diluted EPS | $-0.39 | $-1.08 | $-1.56 | $-1.40 |
| Total assets (year end) | $512.7M | $539.4M | $661.1M | $856.6M |
| Cash and equivalents (year end) | $70.5M | $47.9M | $65.1M | $90.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adaptive Biotechnologies Corp
- Ticker
- ADPT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Seattle, WA
- Incorporated in
- WA
- Fiscal year end
- December 31
- SEC CIK
- 1478320
- Former names
- Adaptive TCR Corp
Frequently asked questions
What exchange is Adaptive Biotechnologies Corp listed on?
Adaptive Biotechnologies Corp trades on the Nasdaq under the ticker symbol ADPT.
What industry is Adaptive Biotechnologies Corp in?
Adaptive Biotechnologies Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Adaptive Biotechnologies Corp headquartered?
Adaptive Biotechnologies Corp's business address on file with the SEC is in Seattle, WA.
When does Adaptive Biotechnologies Corp's fiscal year end?
Adaptive Biotechnologies Corp's fiscal year ends on December 31.
How much revenue did Adaptive Biotechnologies Corp report?
Adaptive Biotechnologies Corp reported $277.0M in revenue for calendar year 2025, according to its SEC filings.